These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 24532095)
1. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride. Stange U; Führling C; Gieseler H J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095 [TBL] [Abstract][Full Text] [Related]
2. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate. Sheshala R; Khan N; Darwis Y Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234 [TBL] [Abstract][Full Text] [Related]
3. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride. Cantor SL; Khan MA; Gupta A Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481 [TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets. Yan YD; Woo JS; Kang JH; Yong CS; Choi HG Biol Pharm Bull; 2010; 33(8):1364-70. PubMed ID: 20686233 [TBL] [Abstract][Full Text] [Related]
5. Freeze drying of orally disintegrating tablets containing taste masked naproxen sodium granules in blisters. Stange U; Führling C; Gieseler H Pharm Dev Technol; 2015 Dec; 20(8):1018-1024. PubMed ID: 25220888 [TBL] [Abstract][Full Text] [Related]
7. Influence of non-water-soluble placebo pellets of different sizes on the characteristics of orally disintegrating tablets manufactured by freeze-drying. Stange U; Führling C; Gieseler H J Pharm Sci; 2013 Jun; 102(6):1786-1799. PubMed ID: 23568590 [TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules. Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Vural İ; Ünlü N Pharm Dev Technol; 2018 Jun; 23(5):488-495. PubMed ID: 28368673 [TBL] [Abstract][Full Text] [Related]
9. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients. Liew KB; Tan YT; Peh KK Drug Dev Ind Pharm; 2015 Apr; 41(4):583-93. PubMed ID: 24495273 [TBL] [Abstract][Full Text] [Related]
10. Taste masking of naproxen sodium granules by fluid-bed coating. Stange U; Führling C; Gieseler H Pharm Dev Technol; 2014 Mar; 19(2):137-47. PubMed ID: 23324020 [TBL] [Abstract][Full Text] [Related]
11. Formulation and evaluation of bitter taste-masked orally disintegrating tablets of high memantine hydrochloride loaded granules coated with polymer via layering technique. Kadota K; Terada H; Fujimoto A; Nogami S; Uchiyama H; Tozuka Y Int J Pharm; 2021 Jul; 604():120725. PubMed ID: 34029663 [TBL] [Abstract][Full Text] [Related]
12. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method. Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500 [TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of unpleasant taste-masked pioglitazone orally disintegrating tablets. Nakano Y; Maeda A; Uchida S; Namiki N Int J Pharm; 2013 Mar; 446(1-2):160-5. PubMed ID: 23419665 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics. Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768 [TBL] [Abstract][Full Text] [Related]
15. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations. Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets. Drašković M; Medarević D; Aleksić I; Parojčić J Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420 [TBL] [Abstract][Full Text] [Related]
17. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying. Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex. Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050 [TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins. Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111 [TBL] [Abstract][Full Text] [Related]
20. Formulation studies for mirtazapine orally disintegrating tablets. Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]